aromasin 25 mg coated tablets
pfizer enterprises sarl - Экземестан - 25 mg coated tablets
anaromat 1 mg film - coated tablets
Актавис ЕАД - Анастрозол - 1 mg film - coated tablets
КОНСТЕЛ®
adama - Суспензионен концентат (СК) - 25 г/л дифлуфеникан + 400 г/л хлоротолурон - Хербициди
locametz
novartis europharm limited - gozetotide - Радиоюклидно изображение - Диагностични радиофармацевтици - Този лекарствен продукт е само за диагностична употреба. locametz, after radiolabelling with gallium 68, is indicated for the detection of prostate specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high risk pca prior to primary curative therapy,suspected pca recurrence in patients with increasing levels of serum prostate specific antigen (psa) after primary curative therapy,identification of patients with psma positive progressive metastatic castration resistant prostate cancer (mcrpc) for whom psma targeted therapy is indicated (see section 4.
pluvicto
novartis europharm limited - lutetium (177lu) vipivotide tetraxetan - Новообразувания На Простатата, Кастраци-Упорит - Терапевтични радиофармацевтици - pluvicto in combination with androgen deprivation therapy (adt) with or without androgen receptor (ar) pathway inhibition is indicated for the treatment of adult patients with progressive prostate-specific membrane antigen (psma)-positive metastatic castration-resistant prostate cancer (mcrpc) who have been treated with ar pathway inhibition and taxane based chemotherapy.
pylclari
curium pet france - piflufolastat (18f) - Простатни неоплазми - Диагностични радиофармацевтици - Този лекарствен продукт е само за диагностична употреба. pylclari is indicated for the detection of prostate-specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high-risk pca prior to initial curative therapy,to localize recurrence of pca in patients with a suspected recurrence based on increasing serum prostate-specific antigen (psa) levels after primary treatment with curative intent. pylclari is indicated for use with positron emission tomography (pet).
КОЛТ®
adama - Суспензионен концентат (СК) - 600 г/л аклонифен - Хербициди
КАЛИФ® 360 КС
adama - Суспензия капсули (КС) - 360 г/л кломазон - Хербициди
ЛЕОПАРД® 5 ЕК
adama - Емулсионен концентрат (ЕК) - 50 г/л хизалофоп-п-етил - Хербициди
ТРИМЕР® СХ
adama - Вододиспергируеми гранули (ВГ) - 500 г/кг трибенурон-метил - Хербициди